Orajel Antiseptic Rinse For All Mouth Sores

Hydrogen Peroxide And Menthol


Church & Dwight Co., Inc.
Human Otc Drug
NDC 10237-760
Orajel Antiseptic Rinse For All Mouth Sores also known as Hydrogen Peroxide And Menthol is a human otc drug labeled by 'Church & Dwight Co., Inc.'. National Drug Code (NDC) number for Orajel Antiseptic Rinse For All Mouth Sores is 10237-760. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Orajel Antiseptic Rinse For All Mouth Sores drug includes Hydrogen Peroxide - 15 mg/mL Menthol, Unspecified Form - 1 mg/mL . The currest status of Orajel Antiseptic Rinse For All Mouth Sores drug is Active.

Drug Information:

Drug NDC: 10237-760
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Orajel Antiseptic Rinse For All Mouth Sores
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Hydrogen Peroxide And Menthol
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Church & Dwight Co., Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:HYDROGEN PEROXIDE - 15 mg/mL
MENTHOL, UNSPECIFIED FORM - 1 mg/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Nov, 2014
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 23 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part356
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Church & Dwight Co., Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:2584344
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:BBX060AN9V
L7T10EIP3A
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
10237-760-16473.2 mL in 1 BOTTLE (10237-760-16)01 Nov, 2014N/ANo
10237-760-481419.5 mL in 1 BOTTLE (10237-760-48)01 Sep, 2021N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Oral debriding agent/oral antiseptic oral pain reliever

Product Elements:

Orajel antiseptic rinse for all mouth sores hydrogen peroxide and menthol hydrogen peroxide hydrogen peroxide menthol, unspecified form menthol, unspecified form fd&c blue no. 1 edetate disodium methyl salicylate phosphoric acid poloxamer 338 polysorbate 20 saccharin sodium sorbitol water alcohol

Indications and Usage:

First aid to help reduce bacteria in minor oral wounds for temporary pain relief and use in cleansing minor wounds or minor gum inflammation resulting from: minor dental procedures accidental injury orthodontic appliances canker sores dentures other irritations of the mouth and gums aids in the removal of: phlegm mucus other secretions associated with occasional sore mouth

Warnings:

When using this product do not swallow do not exceed recommended dosage do not use this product for more than 7 days unless directed by a dentist or healthcare provider stop use and see your physician promptly if swallowing, rash or fever develops; irritation, pain or redness persists or worsens; sore mouth symptoms do not improve in 7 days keep out of reach of children. if more than used for rinsing is accidentally swallowed, get medical help or contact a poison control center right away

Do Not Use:

When using this product do not swallow do not exceed recommended dosage do not use this product for more than 7 days unless directed by a dentist or healthcare provider stop use and see your physician promptly if swallowing, rash or fever develops; irritation, pain or redness persists or worsens; sore mouth symptoms do not improve in 7 days keep out of reach of children. if more than used for rinsing is accidentally swallowed, get medical help or contact a poison control center right away

Dosage and Administration:

Directions remove imprinted safety seal from bottle cap to remove child-resistant cap, squeeze smooth sides of cap while turning. reclose tightly. ready to use, no mixing needed. adults and children 2 years of age and older swish one-half capful (2 tesapoons=10ml) around the mouth over the affected area for at least 1 minute and then spit out. use up to 4 times daily after meals and at bedtime or as directed by a dentist or healthcare provider children under 12 years of age should be supervised in the use of this product children under 2 years of age consult a dentist or healthcare provider

Stop Use:

Stop use and see your physician promptly if swallowing, rash or fever develops; irritation, pain or redness persists or worsens; sore mouth symptoms do not improve in 7 days

Package Label Principal Display Panel:

#1 oral pain reliever brand for adults with pain relief! orajel™ for all mouth sores antiseptic rinse canker sores cheek bites gum irritation irritation from dentures or braces promotes healing kills bacteria provides pain relief soothing mint rinse oral debriding agent / antiseptic rinse / pain reliever 16 fl oz (473.2 ml) da2011184_ojlbf-32499-06_72013522 10237-793 back label

Further Questions:

Questions or comments call us at 1–800–952–5080 m–f 9am–5pm et or visit our website at www.orajel.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.